approval
saveHYMPAVZI (MARSTACIMAB-HNCQ) — FDA approval
community read0 votes
Sponsor: PFIZER INC. Form: INJECTABLE. Route: SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 2
same company · ±60 days · 6
- approvalMETHYLPREDNISOLONE — FDA approvalOct 11, 2024
- approvalMETHYLPREDNISOLONE — FDA approvalOct 11, 2024
- approvalHEPARIN SODIUM: HEPARIN SODIUM — FDA approvalOct 24, 2024
- approvaltofacitinib citrate ER: XELJANZ XR (TOFACITINIB CITRATE) — FDA approvalSep 27, 2024
- approvaltofacitinib citrate ER: XELJANZ (TOFACITINIB CITRATE) — FDA approvalSep 27, 2024
- approvalPAXLOVID (COPACKAGED): PAXLOVID (COPACKAGED) (NIRMATRELVIR) — FDA approvalSep 12, 2024
comments(0)
5-min edit window · permanent after that